Published in TB and Outbreaks Week, June 5th, 2001
Public health experts say the Johns Hopkins Malaria Institute will put the university at the forefront of efforts to find an effective vaccine and new treatments for the mosquito-borne disease, one of the leading killers in developing nations.
"They now have immediately, overnight, assumed the predominant role in the group of people that are involved in malaria research," said Dr. Anthony Fauci, head of the U.S. National Institute of Allergy and Infectious Diseases.
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.